0001209191-13-016611.txt : 20130314 0001209191-13-016611.hdr.sgml : 20130314 20130314175254 ACCESSION NUMBER: 0001209191-13-016611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130313 FILED AS OF DATE: 20130314 DATE AS OF CHANGE: 20130314 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 149 COMMONWEALTH DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TURNER JOSEPH L CENTRAL INDEX KEY: 0001266129 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 13691540 MAIL ADDRESS: STREET 1: 10505 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-03-13 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001266129 TURNER JOSEPH L C/O CORCEPT THERAPEUTICS 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 1 0 0 0 Common stock 2013-03-13 4 P 0 1500 2.00 A 1500 D Common stock 2013-03-14 4 P 0 8500 2.0078 A 10000 D /s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated attorney-in-fact 2013-03-14